Cellix Bio
Newark
About Cellix Bio
Cellix Bio provides medical research services to develop drug products for the treatment of immune and other related diseases. Cellix Bio's services are dedicated to the development of targeted therapies and proprietary molecular therapeutics that enhance the attributes of approved drugs, such as efficacy, therapeutic index, bioavailability, and safety, allowing healthcare professionals to treat chronic ailments faster and reduce recovery times.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $14.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2019)
- Website: cellixbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/cellix-bio-71262 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.